Low-dose ATG/PTCy for graft-versus-host disease prevention in haploidentical transplantation: a single-center experience

BackgroundThe combination of anti-thymocyte globulin (ATG) and post-transplant cyclophosphamide (PTCy) has been administered for graft-versus-host disease (GVHD) prophylaxis of haploidentical hematopoietic stem cell transplantation (haplo-HSCT) in recent years. Varied doses of ATG and PTCy were appl...

詳細記述

書誌詳細

出版年:	Frontiers in Oncology
主要な著者:	Jian Hong, Xinglin Liang, Jing Ni, Min Ruan, Zhangbiao Long, Jifei Dai, Li Liang, Mingya Yang, Ziyang Zhang, Shihao Zhang, Jian Ge, Mingzhen Yang, Qingsheng Li
フォーマット:	論文
言語:	英語
出版事項:	Frontiers Media S.A. 2025-06-01
主題:	anti-thymocyte globulin post-transplant cyclophosphamide graft-versus-host disease haploidentical hematopoietic stem cell transplantation absolute lymphocyte count
オンライン･アクセス:	https://www.frontiersin.org/articles/10.3389/fonc.2025.1569149/full